- /
- Supported exchanges
- / US
- / ETON.NASDAQ
Eton Pharmaceuticals Inc (ETON NASDAQ) stock market data APIs
Eton Pharmaceuticals Inc Financial Data Overview
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eton Pharmaceuticals Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Eton Pharmaceuticals Inc data using free add-ons & libraries
Get Eton Pharmaceuticals Inc Fundamental Data
Eton Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 106 M
- EBITDA: 25 178 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Eton Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: 0.34
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eton Pharmaceuticals Inc News
New
Aquestive rises on licensing deal with Eton for antiseizure therapy
[Two coloured ropes knotted together] Richard Drury Shares of Aquestive Therapeutics (AQST [https://seekingalpha.com/symbol/AQST]) rose in premarket trading on Wednesday after the company reached an ...
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know
Shares of TG Therapeutics TGTX have risen 59.9% in the past six months, driven by the robust sales performance of its sole marketed drug, Briumvi (ublituximab-xiiy). The company's top line primarily c...
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Mirum Pharmaceuticals MIRM announced that the phase III EXPAND study, which evaluated Livmarli (maralixibat) for treating cholestatic pruritus in patients aged six months and older with ultra-rare cho...
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
Shares of Eton Pharmaceuticals ETON have gained about 108% over the past six months compared with the industry's 0.7% growth, fueled by growing investor confidence in the company's strong commercial e...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.